Daniel G. Silva - Search Results

Year	Number of Results
2010	1
2012	1
2016	1
2017	3
2020	3
2021	4
2022	1
2023	0

1

Development of Novel Isoindolone-Based Compounds against Trypanosoma brucei rhodesiense.

Silva DG, Feijens PB, Hendrickx R, Matheeussen A, Grey L, Caljon G, Maes L, Emery FS, Junker A. Silva DG, et al. ChemistryOpen. 2021 Sep;10(9):922-927. doi: 10.1002/open.202100180. ChemistryOpen. 2021. PMID: 34553828 Free PMC article.

2

Synthesis and Structure-Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against Trypanosomiases.

Silva DG, Junker A, de Melo SMG, Fumagalli F, Gillespie JR, Molasky N, Buckner FS, Matheeussen A, Caljon G, Maes L, Emery FS. Silva DG, et al. ChemMedChem. 2021 Mar 18;16(6):966-975. doi: 10.1002/cmdc.202000616. Epub 2020 Nov 11. ChemMedChem. 2021. PMID: 33078573 Free PMC article.

3

Estuarine Aquacultures at the Crossroads of Animal Production and Antibacterial Resistance: A Metagenomic Approach to the Resistome.

Silva DG, Domingues CPF, Figueiredo JF, Dionisio F, Botelho A, Nogueira T. Silva DG, et al. Biology (Basel). 2022 Nov 21;11(11):1681. doi: 10.3390/biology11111681. Biology (Basel). 2022. PMID: 36421395 Free PMC article.

4

New Class of Antitrypanosomal Agents Based on Imidazopyridines.

Silva DG, Gillespie JR, Ranade RM, Herbst ZM, Nguyen UTT, Buckner FS, Montanari CA, Gelb MH. Silva DG, et al. ACS Med Chem Lett. 2017 Jun 27;8(7):766-770. doi: 10.1021/acsmedchemlett.7b00202. eCollection 2017 Jul 13. ACS Med Chem Lett. 2017. PMID: 28740614 Free PMC article.

5

Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors.

Wagner S, de Moura Gatti F, Silva DG, Ortiz Zacarias NV, Zweemer AJM, Hermann S, De Maria M, Koch M, Weiss C, Schepmann D, Heitman LH, Tschammer N, Kopka K, Junker A. Wagner S, et al. Among authors: silva dg. ChemMedChem. 2021 Feb 17;16(4):640-645. doi: 10.1002/cmdc.202000728. Epub 2020 Nov 23. ChemMedChem. 2021. PMID: 33205603 Free PMC article.

6

On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.

Bonatto V, Batista PHJ, Cianni L, De Vita D, Silva DG, Cedron R, Tezuka DY, de Albuquerque S, Moraes CB, Franco CH, Lameira J, Leitão A, Montanari CA. Bonatto V, et al. Among authors: silva dg. RSC Med Chem. 2020 Sep 9;11(11):1275-1284. doi: 10.1039/d0md00097c. eCollection 2020 Nov 18. RSC Med Chem. 2020. PMID: 34095840 Free PMC article.

7

Anterior thalamic NMDA-induced damage impairs extrapolation relying on serial stimulus patterns, in rats.

Silva DG, Xavier GF. Silva DG, et al. Neurobiol Learn Mem. 2021 Nov;185:107536. doi: 10.1016/j.nlm.2021.107536. Epub 2021 Oct 8. Neurobiol Learn Mem. 2021. PMID: 34634435 Free article.

8

A comparative study of warheads for design of cysteine protease inhibitors.

Silva DG, Ribeiro JFR, De Vita D, Cianni L, Franco CH, Freitas-Junior LH, Moraes CB, Rocha JR, Burtoloso ACB, Kenny PW, Leitão A, Montanari CA. Silva DG, et al. Bioorg Med Chem Lett. 2017 Nov 15;27(22):5031-5035. doi: 10.1016/j.bmcl.2017.10.002. Epub 2017 Oct 3. Bioorg Med Chem Lett. 2017. PMID: 29054358

9

Highly predictive hologram QSAR models of nitrile-containing cruzain inhibitors.

Silva DG, Rocha JR, Sartori GR, Montanari CA. Silva DG, et al. J Biomol Struct Dyn. 2017 Nov;35(15):3232-3249. doi: 10.1080/07391102.2016.1252282. Epub 2016 Nov 28. J Biomol Struct Dyn. 2017. PMID: 27809673

10

MIA-QSAR modeling of the anti-HIV-1 protease activities and cytotoxicities of ritonavir analogs.

Silva DG, Freitas MP. Silva DG, et al. Curr Drug Saf. 2012 Sep;7(4):269-81. doi: 10.2174/157488612804096588. Curr Drug Saf. 2012. PMID: 23062239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results